![]()
|
Report Date : |
24.07.2008 |
IDENTIFICATION
DETAILS
|
Name : |
P.D.H. LABORATORIES (PVT) LIMITED |
|
|
|
|
Registered Office : |
19 - K.M., Ferozepur Road, Lahore |
|
|
|
|
Country : |
Pakistan |
|
|
|
|
Year of Establishment : |
1970 |
|
|
|
|
Com. Reg. No.: |
0003171 |
|
|
|
|
Legal Form : |
Private Limited Company |
|
|
|
|
Line of Business : |
Manufacture & Marketing of
Pharmaceutical Products |
RATING &
COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
P.D.H. LABORATORIES (PVT) LIMITED
Registered Address
& Factory
19 - K.M., Ferozepur Road, Lahore, Pakistan
Tel 92 (42) 5824496, 5824497
Fax 92 (42) 5823425 5821026
Websites : pdhexp_2008@yahoo.com, saeedshb@hotmail.com
|
a. |
Nature of
Business |
Manufacture & Marketing of Pharmaceutical Products
|
|
b. |
Year Established |
1970 |
|
c. |
Registration # |
0003171 |
In Lahore & Karachi at present
A. Aziz Chaudhury & Co.
(Chartered
Accountants)
38, Shahrah-e-Quaid-e-Azam, Lahore, Pakistan
Subject Company was established as a Private
Limited Company in 1970
|
Authorized Capital |
Rs. 10,000,000/- divided into 1,000,000
shares of Rs. 10/- each |
|
Issued & Paid up Capital |
Rs. 8,540,910/- divided into 854,091 shares
of Rs. 10/- each |
|
Names |
Nationality |
Address |
Occupation |
Designation |
|
Mr .Sheikh Muhammad Ilyas Mr .Sheikh Muhammad Altaf Mr. Jamil Altaf Mr. Mohsin Ilyas Mr. Ghulam Mustafa Ilyas |
Pakistani Pakistani Pakistani Pakistani Pakistani |
31-B-3, Gulberg
III, Lahore 31-B-3, Gulberg
III, Lahore 31-B-3, Gulberg
III, Lahore 31-B-3, Gulberg
III, Lahore 31-B-3, Gulberg
III, Lahore |
Business Business Business Business Business |
Chief Executive Director Director Director Director |
Names
Mr .Sheikh Muhammad Ilyas
Mr .Sheikh Muhammad Altaf
Mr. Jamil Altaf
Mr. Mohsin Ilyas
Mr. Ghulam Mustafa Ilyas
A. Subsidiary
None
B. Associated
Companies
P.D.H. Pharmaceuticals (Pvt) Limited, Pakistan.
Manufacture &
Marketing of Pharmaceutical Products by its brand names of ADECAINE, ADRENALINE,
ALKACITRON, ALLERPHENE, AMIKOSIDE, AMMODRYL, AMPLIPEN, ANAMOL, APOCLOX,
BELEXVIT FORTE, BENZYL, PENCILLIN, BETACORT, BETACORT-N, BUTAMIN, CALCIUM-P,
CEFLOREX, CEFUZIN, CEPHRONATE, CEZINE, CHLORMIC, CHLOROQUINE INJ, CLOSTECIN,
COLITRAN, CORINOR, DYNACEF, EPHAZOL-C, EPHEDRINE INJ, EYEFLOX, FAMRON,
FERRODIN, FLOXOL, GESNOR, GIOZAR, HYPNOTIL, IBUMID, ISONIAZID TABS, KAOMAGMA,
KUIN, KUINOPT, LIPONORM, LYSOMEL, MALIDAR, MEFADIL, MELCO-6, MYCLAR, NALBINOR,
NEO-PHENICOL, NEOBREX, OMECER, OXYTETRACYCLINE, PANBUTOL, PANOCID, PARACETAMOL
TABS, PARACODEINE, PENBRO, PETHIDINE, POLYBIOTIC, POLYVIT, POLYVIT-M, POTASSIUM
CHLORIDE, QUEST, RIMODIN, SOMNITE, STREPTOMYCIN INJ, ULTICOMB, UROLAX,
VISTAGAN, ZEVIROL, ZINCOCID
225
MURLI KRISHNA (PVT) LIMITED, INDIA.
ZHUHAI UNITED LABORATORIES CO., LTD, CHINA.
GUJARAT GLASS (PVT) LIMITED, INDIA.
The capacity and production of the company’s plant is
indeterminable as it involves varying processes of manufacture.
|
Year |
In Pak Rupees |
|
2006 |
200,000,000/- (Estimated) |
Mainly in all
major cities of Pakistan
Allied Bank Limited, 199-Upper Mall Branch, Lahore, Pakistan.
Meezan Bank Limited, Shadman Branch, Lahore, Pakistan.
Bank Alfalah Limited, Main Boulevard, Gulberg, Lahore, Pakistan.
Habib Bank Limited, Main Market, Gulberg, Lahore, Pakistan.
Habib Metropolitan Bank Limited, Davis Road, Lahore, Pakistan.
|
Currency |
Unit |
Pakistani Rupee |
|
US Dollar |
1 |
Rs. 71.60 |
|
UK Pound |
1 |
Rs. 142.80 |
|
Euro |
1 |
Rs. 113.40 |
Subject Company was established in 1970 and
is engaged in manufacture & marketing of Pharmaceutical Products.Overall reputation
is satisfactory. Trade relations are reported as fair. The Company can be
considered for normal business dealings at usual trade terms & conditions.
FOREIGN EXCHANGE
RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs. 41.96 |
|
UK Pound |
1 |
Rs.83.78 |
|
Euro |
1 |
Rs.65.82 |
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history (10%) Market
trend (10%) Operational
size (10%)